These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5994041)

  • 1. Standards for modified strain vaccines in foot-and-mouth disease.
    Brooksby JB
    Bull Off Int Epizoot; 1966; 65(11):1941-7. PubMed ID: 5994041
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apropos of the conclusions (Point I, Section E) of the 11th conference of the Permanent Commission on Foot-and-Mouth Disease of the International Office of Epizootic Diseases in Paris].
    Röhrer H
    Bull Off Int Epizoot; 1966; 65(11):1921-8. PubMed ID: 5994040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strains of foot-and-mouth viruses which can be used for live vaccines].
    Onoufriev V
    Bull Off Int Epizoot; 1966; 65(11):1967-73. PubMed ID: 5994042
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination against foot-and-mouth disease.
    Morgan DO; Moore DM; McKercher PD
    Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenic properties of inactivated cultured foot-and-mouth disease vaccine].
    Siusiukin AA; Kravets IK; Siusiukina MS; Efimov NI; Sergeev VA; Mel'nik RI
    Veterinariia; 1967 Apr; 44(4):17-8. PubMed ID: 5615318
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative immunologic study on cattle of 2 strains of foot-and-mouth disease type O virus: O Flanders and O Spain 64].
    Fontaine J; Gayot G; Dubouclard C; Dhennin L; Roumiantzeff M; Terre J; Dhennin L
    Bull Off Int Epizoot; 1966; 65(11):2051-62. PubMed ID: 5994044
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the immunizing properties of GOAL-formol vaccine and GNKI dry virus vaccine against foot-and-mouth disease].
    Lazarev PS; Amelin IP; Zaslonov MS
    Veterinariia; 1966 Sep; 43(9):30-1. PubMed ID: 6011469
    [No Abstract]   [Full Text] [Related]  

  • 9. [An alternative method for the control of anti-aphthae vaccines].
    Leunen J; Strobbe R
    Bull Mem Acad R Med Belg; 1986; 141(5-6):335-42. PubMed ID: 3026535
    [No Abstract]   [Full Text] [Related]  

  • 10. [Examination of foot-and-mouth disease virus strains with regard to their suitability for modified virus vaccine preparation].
    Wittmann G; Ahl R; Bauer K
    Bull Off Int Epizoot; 1966; 65(11):1901-20. PubMed ID: 4297170
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of immunologicals in the European union: current and emerging issues.
    Kriz NG;
    Biologicals; 2005 Dec; 33(4):247-52. PubMed ID: 16289997
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
    Orsel K
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the current state of research on the development of foot-and-mouth disease vaccines for pigs].
    Mussgay M; Wittmann G
    Berl Munch Tierarztl Wochenschr; 1968 Apr; 81(7):124-8. PubMed ID: 5693632
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of an emergency vaccine against foot and mouth disease in pigs].
    Eblé P
    Tijdschr Diergeneeskd; 2007 Aug; 132(16):617-9. PubMed ID: 17849910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative testing of methods for the control of foot-and-mouth disease vaccines on guinea pigs].
    Tekerlekov P; Mitev G; Nikolova E; Gergov P
    Vet Med Nauki; 1975; 12(1):25-9. PubMed ID: 1209994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.
    Goris N; Maradei E; D'Aloia R; Fondevila N; Mattion N; Perez A; Smitsaart E; Nauwynck HJ; La Torre J; Palma E; De Clercq K
    Vaccine; 2008 Jun; 26(27-28):3432-7. PubMed ID: 18499310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonising testing requirements for FMD vaccines.
    Mackay D
    Dev Biol (Basel); 2004; 119():383-6. PubMed ID: 15742651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary study of the synergy of variants in the matter of foot-and-mouth disease. Action on the immunogenic quality of antiaphthous vaccines].
    Fontaine J; Roumiantzeff M; Dubouclard C; Mackowiak C
    Bull Acad Vet Fr; 1966 Jun; 39(6):229-37. PubMed ID: 6006997
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in prevention of foot-and-mouth disease].
    Kuznetsov NN
    Veterinariia; 1970 Jun; 6():49-50. PubMed ID: 5529605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.